Improving memory and learning in Portuguese patients with Multiple Sclerosis
Official title: Testing the Efficacy of a Memory Training Program to Improve New Learning and Memory in Portuguese Patients With Multiple Sclerosis: A Randomized Clinical Trial
Run by Centro Hospitalar De São João, E.P.E. · NCT06723444 · Data updated 2026-11-12
This study is testing a new memory training program to see if it can help people in Portugal with Multiple Sclerosis improve their memory and learning skills.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Centro Hospitalar De São João, E.P.E. Academic / other |
| Locations | 1 site (Porto) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | December 2026 |
| Study ends | August 2028 |
| Registry record updated | February 12, 2025 |
| Trial ID | NCT06723444 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult native Portuguese speakers with a confirmed diagnosis of MS and documented impairments in new learning abilities.
✕Probably not a fit
Patients with recent exacerbations, significant neurological histories, or those on certain medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to address memory and learning deficits commonly experienced by patients with Multiple Sclerosis (MS) in Portugal. It will implement the Modified Story Memory Technique (mSMT), a cognitive rehabilitation program designed to enhance memory through structured sessions that incorporate visual imagery and contextual learning. Participants will be randomly assigned to either a memory retraining group or a placebo control group, with assessments conducted at baseline, immediately after the intervention, and during long-term follow-ups to evaluate cognitive function and daily life impacts. The study seeks to fill a gap in existing research by testing the efficacy of mSMT specifically in the Portuguese MS population.
Why it matters
Potential benefit: If successful, this intervention could significantly improve cognitive function and quality of life for patients with Multiple Sclerosis.
How similar studies have gone: Previous studies have shown the effectiveness of similar cognitive rehabilitation techniques in various populations, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * established diagnosis of MS, according to McDonald criteria; * adult native Portuguese speakers; * at least four years of education; * free of exacerbations and use of steroids for at least one month, and no neurologic history other than MS; * no history of major depressive disorder, schizophrenia, bipolar disorder, and no history of substance use/dependence; * no significant visual impairment that impacts the ability to see testing materials and language comprehension as measured by the Token Test; * impaired verbal new learning as documented by a performance of -1.0 or worse standard deviations below the mean, using age, sex and education-adjusted Portuguese norms on the Selective Reminding Test from the Brief Repeatable Battery of Neuropsychological Tests. Exclusion Criteria: * an exacerbation within one month; * neurological history of head injury, stroke, seizures, or any other significant neurological history; * patients on steroids, benzodiazepines, and/or neuroleptics; * patients with an active diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder; * poor visual acuity, diplopia, or nystagmus; * inability to understand directions and following one, two, and three step commands; * and intact new learning and memory.
Where it's running
-
Centro Hospitalar Universitário de São João
Porto, Portugal Recruiting
Study contacts
- Study coordinator: Márcia França, Master's Degree
- Email: marcia.franca.mf@gmail.com
- Phone: +351965495454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.